Clinical Trials
2,795 trialsEvaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
University of Kentucky
Female Fertility Preservation Using Ovarian Tissue Cryopreservation Before Highly Gonadotoxic Cancer Treatment
University Hospital, Geneva
Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment
University Hospital, Geneva
Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors
University of California, San Diego
Pan Tumor Rollover Study
Bristol-Myers Squibb
Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer
M.D. Anderson Cancer Center
A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer
Boehringer Ingelheim
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
GlaxoSmithKline
Spanish Meaning-Centered Psychotherapy for Cancer
University of Valencia
MOBITEP
Centre Hospitalier Régional d'Orléans
MICROBLADDERK
Centre Hospitalier Universitaire de Nice
Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway
Wake Forest University Health Sciences
KANDLELIT-014
Merck Sharp & Dohme LLC
COMUNICAR: Community-Led Family-Centered Communication for Cancer Survivorship Care
Stanford University
Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
National Institutes of Health Clinical Center (CC)
Galleri® in the Medicare Population.
GRAIL, Inc.
MCW I-PREDICT
Medical College of Wisconsin
BEHOLD-1
GlaxoSmithKline
PanTumor-101
GlaxoSmithKline
BEHOLD-2
GlaxoSmithKline
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
AbbVie
ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment Area
H. Lee Moffitt Cancer Center and Research Institute
RELAX
Wake Forest University Health Sciences
Testing Alcohol Cancer Risk Messages
University of Miami
Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
Merck Sharp & Dohme LLC
Bright IDEAS - Young Adults Problem-Solving Skills Training
Rutgers, The State University of New Jersey
Supportive Oncology Care at Home Post-Discharge
Massachusetts General Hospital
NOSH
VA Office of Research and Development
TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer
The University of Hong Kong
CEICS
Chulabhorn Cancer Center
Nano-X
University of Sydney
Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (Pembrolizumab) in Advanced or Metastatic Malignancy
Lyvgen Biopharma Holdings Limited
Nano-X IG
University of Sydney
Phase 1 Trial of LVGN7409 (CD40 Agonist Antibody) as Single Agent and Combination Therapies in Advanced or Metastatic Malignancy
Lyvgen Biopharma Holdings Limited
ROSY-D
AstraZeneca
Comparing the Effects of Art Therapy and Mandala Application on State Anxiety Levels in Chemotherapy Patients
Atlas University
Telerehabilitation-Based Dance Therapy in Pediatric Cancer
Akdeniz University
A Study of a Telemedicine Program for Older Adults With Cancer
Memorial Sloan Kettering Cancer Center
Meraki_Cancer
University of Valencia
Safety of Anal Curcumin
Emory University
Laughter Yoga Effect on Cancer Patients' Physiopsychological Symptoms
Ataturk University
Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms
Jonsson Comprehensive Cancer Center
CASA
Ponce Medical School Foundation, Inc.
A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)
Weill Medical College of Cornell University
ACTIVE
Universität Duisburg-Essen
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
M.D. Anderson Cancer Center
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Eastern Cooperative Oncology Group
Yoga to Improve Disparities in Cancer Survivorship
University of California, San Francisco